Nesiritide (BNP) in the management of postoperative cardiac patients

Nader Moazami, Ralph J. Damiano, Marci S. Bailey, Rachel L. Hess, Jennifer S. Lawton, Marc R. Moon, Michael K. Pasque

Research output: Contribution to journalArticle

Abstract

Recombinant human B-type natriuretic peptide (BNP) is a promising new agent in the management of heart failure. The pharmacologic properties of BNP make it desirable to use in a subset of patients after cardiac surgical operations. Among these therapeutic potentials is the effect on markedly reducing pulmonary vascular resistance and central venous pressure with mild systemic vasodilatation. In addition, BNP directly effects the kidneys to promote natriuresis. We believe this agent to be useful in the treatment of the postcardiac surgery patients with left ventricular dysfunction and mild to moderate renal insufficiency. This report summarizes our experience in 2 patients.

Original languageEnglish (US)
Pages (from-to)1974-1976
Number of pages3
JournalAnnals of Thoracic Surgery
Volume75
Issue number6
DOIs
StatePublished - Jun 1 2003
Externally publishedYes

ASJC Scopus subject areas

  • Surgery
  • Pulmonary and Respiratory Medicine
  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Nesiritide (BNP) in the management of postoperative cardiac patients'. Together they form a unique fingerprint.

  • Cite this

    Moazami, N., Damiano, R. J., Bailey, M. S., Hess, R. L., Lawton, J. S., Moon, M. R., & Pasque, M. K. (2003). Nesiritide (BNP) in the management of postoperative cardiac patients. Annals of Thoracic Surgery, 75(6), 1974-1976. https://doi.org/10.1016/S0003-4975(02)05009-9